The novel and selective insulin-like growth factor-1 receptor kinase inhibitor pqip suppresses bone cell function and osteoclast-breast cancer cell cross-talk

被引：0
|
作者：
Logan, J. G. [1 ,2 ]
Sophocleous, A. [1 ]
Landao-Bassonga, E. [1 ]
Brunton, V. G. [2 ]
Idris, A. I. [1 ,2 ]
机构：
[1] Univ Edinburgh, Inst Genet & Mol Med, Ctr Mol Med, Edinburgh, Midlothian, Scotland
[2] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland
来源：
BONE | 2011年 / 48卷
关键词：
D O I：
10.1016/j.bone.2011.03.631
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S257 / S257
页数：1
相关论文
共 50 条
  • [1] The novel and selective insulin-like growth factor-1 receptor kinase inhibitor PQIP suppresses bone cell function and osteoclast-breast cancer cell cross-talk in vitro
    Logan, J. G.
    Landao-Bassonga, E.
    Brunton, V. G.
    Idris, A. I.
    BONE, 2011, 48 (01) : S43 - S43
  • [2] Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer
    Lee, AV
    Cui, XJ
    Oesterreich, S
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 4429S - 4435S
  • [3] A Type I Insulin-Like Growth Factor Receptor Kinase Inhibitor (PQIP) Enhances the Cytotoxicity of Doxorubicin in Human Cancer Cell Lines.
    Zeng, X.
    Buck, E.
    Yee, D.
    CANCER RESEARCH, 2009, 69 (24) : 859S - 860S
  • [4] Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis
    Logan, John G.
    Sophocleous, Antonia
    Marino, Silvia
    Muir, Morwenna
    Brunton, Valerie G.
    Idris, Aymen I.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (05) : 1229 - 1242
  • [5] A novel unidirectional cross-talk from the insulin-like growth factor-I receptor to leptin receptor in human breast cancer cells
    Ozbay, Tuba
    Nahta, Rita
    MOLECULAR CANCER RESEARCH, 2008, 6 (06) : 1052 - 1058
  • [6] Osteoclast Cancer Cell Metabolic Cross-talk Confers PARP Inhibitor Resistance in Bone Metastatic Breast Cancer
    Fan, Huijuan
    Xu, Zhanao
    Yao, Ke
    Zheng, Bingxin
    Zhang, Yuan
    Wang, Xuxiang
    Zhang, Tengjiang
    Li, Xuan
    Hu, Haitian
    Yue, Bin
    Hu, Zeping
    Zheng, Hanqiu
    CANCER RESEARCH, 2024, 84 (03) : 449 - 467
  • [7] Elucidating the mechanism of estrogen and insulin-like growth factor-1 (IGF-1) cross-talk in uterine cancer.
    Zecevic, M
    Stancel, GM
    Barrett, CJ
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1148S - 1148S
  • [8] Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth
    Girnita, A
    Girnita, L
    del Prete, F
    Bartolazzi, A
    Larsson, O
    Axelson, M
    CANCER RESEARCH, 2004, 64 (01) : 236 - 242
  • [9] Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle
    Grounds, Miranda D.
    Radley, Hannah G.
    Gebski, Bijanka L.
    Bogoyevitch, Marie A.
    Shavlakadze, Thea
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2008, 35 (07): : 846 - 851
  • [10] Clinicopathological significance of insulin-like growth factor-1 receptor expression in breast cancer
    Sahin, Sevinc
    Cakir, Asli
    Gonul, Ipek Isik
    Seckin, Selda
    Uluoglu, Omer
    ANNALI ITALIANI DI CHIRURGIA, 2020, 91 (06) : 583 - 591
12345